Tag: EMA standards
Bioequivalence standards for generic drugs have long ignored batch-to-batch variability, risking false conclusions. New guidelines now require multi-batch testing to ensure real-world equivalence and patient safety.
Categories
Archives
Recent-posts
Deficiency Letters in Generic Drug Applications: Common FDA Findings and How to Avoid Them
Jan, 16 2026

Medications